Crowley John F's Form 4 filing
Amicus Therapeutics, Inc. (FOLD) · filed Feb 3, 2023
- Accession no.
- 0001209191-23-007119
- Filed
- Feb 3, 2023
- Trade date
- Feb 1, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.93M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Crowley John FCIK 0001400973 | Director, Officer (Executive Chairman) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | MOption exerciseAcquired | +83,333 | $6.10 | +$508,331.3 | 1,095,389 | Direct | |
| Feb 1, 2023 | Common Stock | MOption exerciseAcquired | +56,596 | $5.13 | +$290,337.48 | 1,151,985 | Direct | |
| Feb 1, 2023 | Common Stock | SSaleDisposed | −147,316 | $13.11F2 | −$1,931,312.76 | 1,004,669 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | MOption exerciseDisposed | −83,333 | $0.00 | $0 | 0 | Direct | |
| Feb 1, 2023 | Common Stock | MOption exerciseDisposed | −56,596 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $12.81 to $13.28 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Remarks
In addition to the reported transactions which were undertaken for estate planning purposes, Mr. Crowley also has approximately 627,000 options outstanding and exercisable at various strike prices.